Global Therapeutic Nuclear Drug Market Size, Status and Forecast 2024-2031

Report ID: 922387 | Published Date: Sep 2024 | No. of Page: 105 | Base Year: 2023 | Rating: 4.1 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Therapeutic Nuclear Drug Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 Radium-223
        1.2.3 Lutetium-177
        1.2.4 Iodine-131
        1.2.5 Other
    1.3 Market by Application
        1.3.1 Global Therapeutic Nuclear Drug Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Thyroid
        1.3.3 Bone Metastasis
        1.3.4 Lymphoma
        1.3.5 Other
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global Therapeutic Nuclear Drug Market Perspective (2016-2027)
    2.2 Therapeutic Nuclear Drug Growth Trends by Regions
        2.2.1 Therapeutic Nuclear Drug Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 Therapeutic Nuclear Drug Historic Market Share by Regions (2016-2021)
        2.2.3 Therapeutic Nuclear Drug Forecasted Market Size by Regions (2022-2027)
    2.3 Therapeutic Nuclear Drug Industry Dynamic
        2.3.1 Therapeutic Nuclear Drug Market Trends
        2.3.2 Therapeutic Nuclear Drug Market Drivers
        2.3.3 Therapeutic Nuclear Drug Market Challenges
        2.3.4 Therapeutic Nuclear Drug Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Therapeutic Nuclear Drug Players by Revenue
        3.1.1 Global Top Therapeutic Nuclear Drug Players by Revenue (2016-2021)
        3.1.2 Global Therapeutic Nuclear Drug Revenue Market Share by Players (2016-2021)
    3.2 Global Therapeutic Nuclear Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by Therapeutic Nuclear Drug Revenue
    3.4 Global Therapeutic Nuclear Drug Market Concentration Ratio
        3.4.1 Global Therapeutic Nuclear Drug Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Therapeutic Nuclear Drug Revenue in 2020
    3.5 Therapeutic Nuclear Drug Key Players Head office and Area Served
    3.6 Key Players Therapeutic Nuclear Drug Product Solution and Service
    3.7 Date of Enter into Therapeutic Nuclear Drug Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Therapeutic Nuclear Drug Breakdown Data by Type
    4.1 Global Therapeutic Nuclear Drug Historic Market Size by Type (2016-2021)
    4.2 Global Therapeutic Nuclear Drug Forecasted Market Size by Type (2022-2027)

5 Therapeutic Nuclear Drug Breakdown Data by Application
    5.1 Global Therapeutic Nuclear Drug Historic Market Size by Application (2016-2021)
    5.2 Global Therapeutic Nuclear Drug Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America Therapeutic Nuclear Drug Market Size (2016-2027)
    6.2 North America Therapeutic Nuclear Drug Market Size by Type
        6.2.1 North America Therapeutic Nuclear Drug Market Size by Type (2016-2021)
        6.2.2 North America Therapeutic Nuclear Drug Market Size by Type (2022-2027)
        6.2.3 North America Therapeutic Nuclear Drug Market Size by Type (2016-2027)
    6.3 North America Therapeutic Nuclear Drug Market Size by Application
        6.3.1 North America Therapeutic Nuclear Drug Market Size by Application (2016-2021)
        6.3.2 North America Therapeutic Nuclear Drug Market Size by Application (2022-2027)
        6.3.3 North America Therapeutic Nuclear Drug Market Size by Application (2016-2027)
    6.4 North America Therapeutic Nuclear Drug Market Size by Country
        6.4.1 North America Therapeutic Nuclear Drug Market Size by Country (2016-2021)
        6.4.2 North America Therapeutic Nuclear Drug Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe Therapeutic Nuclear Drug Market Size (2016-2027)
    7.2 Europe Therapeutic Nuclear Drug Market Size by Type
        7.2.1 Europe Therapeutic Nuclear Drug Market Size by Type (2016-2021)
        7.2.2 Europe Therapeutic Nuclear Drug Market Size by Type (2022-2027)
        7.2.3 Europe Therapeutic Nuclear Drug Market Size by Type (2016-2027)
    7.3 Europe Therapeutic Nuclear Drug Market Size by Application
        7.3.1 Europe Therapeutic Nuclear Drug Market Size by Application (2016-2021)
        7.3.2 Europe Therapeutic Nuclear Drug Market Size by Application (2022-2027)
        7.3.3 Europe Therapeutic Nuclear Drug Market Size by Application (2016-2027)
    7.4 Europe Therapeutic Nuclear Drug Market Size by Country
        7.4.1 Europe Therapeutic Nuclear Drug Market Size by Country (2016-2021)
        7.4.2 Europe Therapeutic Nuclear Drug Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific Therapeutic Nuclear Drug Market Size (2016-2027)
    8.2 Asia-Pacific Therapeutic Nuclear Drug Market Size by Type
        8.2.1 Asia-Pacific Therapeutic Nuclear Drug Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific Therapeutic Nuclear Drug Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific Therapeutic Nuclear Drug Market Size by Type (2016-2027)
    8.3 Asia-Pacific Therapeutic Nuclear Drug Market Size by Application
        8.3.1 Asia-Pacific Therapeutic Nuclear Drug Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific Therapeutic Nuclear Drug Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific Therapeutic Nuclear Drug Market Size by Application (2016-2027)
    8.4 Asia-Pacific Therapeutic Nuclear Drug Market Size by Region
        8.4.1 Asia-Pacific Therapeutic Nuclear Drug Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific Therapeutic Nuclear Drug Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America Therapeutic Nuclear Drug Market Size (2016-2027)
    9.2 Latin America Therapeutic Nuclear Drug Market Size by Type
        9.2.1 Latin America Therapeutic Nuclear Drug Market Size by Type (2016-2021)
        9.2.2 Latin America Therapeutic Nuclear Drug Market Size by Type (2022-2027)
        9.2.3 Latin America Therapeutic Nuclear Drug Market Size by Type (2016-2027)
    9.3 Latin America Therapeutic Nuclear Drug Market Size by Application
        9.3.1 Latin America Therapeutic Nuclear Drug Market Size by Application (2016-2021)
        9.3.2 Latin America Therapeutic Nuclear Drug Market Size by Application (2022-2027)
        9.3.3 Latin America Therapeutic Nuclear Drug Market Size by Application (2016-2027)
    9.4 Latin America Therapeutic Nuclear Drug Market Size by Country
        9.4.1 Latin America Therapeutic Nuclear Drug Market Size by Country (2016-2021)
        9.4.2 Latin America Therapeutic Nuclear Drug Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Therapeutic Nuclear Drug Market Size (2016-2027)
    10.2 Middle East & Africa Therapeutic Nuclear Drug Market Size by Type
        10.2.1 Middle East & Africa Therapeutic Nuclear Drug Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa Therapeutic Nuclear Drug Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa Therapeutic Nuclear Drug Market Size by Type (2016-2027)
    10.3 Middle East & Africa Therapeutic Nuclear Drug Market Size by Application
        10.3.1 Middle East & Africa Therapeutic Nuclear Drug Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa Therapeutic Nuclear Drug Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa Therapeutic Nuclear Drug Market Size by Application (2016-2027)
    10.4 Middle East & Africa Therapeutic Nuclear Drug Market Size by Country
        10.4.1 Middle East & Africa Therapeutic Nuclear Drug Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa Therapeutic Nuclear Drug Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 Bayer
        11.1.1 Bayer Company Details
        11.1.2 Bayer Business Overview
        11.1.3 Bayer Therapeutic Nuclear Drug Introduction
        11.1.4 Bayer Revenue in Therapeutic Nuclear Drug Business (2016-2021)
        11.1.5 Bayer Recent Development
    11.2 Novartis
        11.2.1 Novartis Company Details
        11.2.2 Novartis Business Overview
        11.2.3 Novartis Therapeutic Nuclear Drug Introduction
        11.2.4 Novartis Revenue in Therapeutic Nuclear Drug Business (2016-2021)
        11.2.5 Novartis Recent Development
    11.3 China Isotope & Radiation
        11.3.1 China Isotope & Radiation Company Details
        11.3.2 China Isotope & Radiation Business Overview
        11.3.3 China Isotope & Radiation Therapeutic Nuclear Drug Introduction
        11.3.4 China Isotope & Radiation Revenue in Therapeutic Nuclear Drug Business (2016-2021)
        11.3.5 China Isotope & Radiation Recent Development
    11.4 Dongcheng
        11.4.1 Dongcheng Company Details
        11.4.2 Dongcheng Business Overview
        11.4.3 Dongcheng Therapeutic Nuclear Drug Introduction
        11.4.4 Dongcheng Revenue in Therapeutic Nuclear Drug Business (2016-2021)
        11.4.5 Dongcheng Recent Development
    11.5 Q BioMed
        11.5.1 Q BioMed Company Details
        11.5.2 Q BioMed Business Overview
        11.5.3 Q BioMed Therapeutic Nuclear Drug Introduction
        11.5.4 Q BioMed Revenue in Therapeutic Nuclear Drug Business (2016-2021)
        11.5.5 Q BioMed Recent Development
    11.6 Curium Pharmaceuticals
        11.6.1 Curium Pharmaceuticals Company Details
        11.6.2 Curium Pharmaceuticals Business Overview
        11.6.3 Curium Pharmaceuticals Therapeutic Nuclear Drug Introduction
        11.6.4 Curium Pharmaceuticals Revenue in Therapeutic Nuclear Drug Business (2016-2021)
        11.6.5 Curium Pharmaceuticals Recent Development
    11.7 Jubilant DraxImage
        11.7.1 Jubilant DraxImage Company Details
        11.7.2 Jubilant DraxImage Business Overview
        11.7.3 Jubilant DraxImage Therapeutic Nuclear Drug Introduction
        11.7.4 Jubilant DraxImage Revenue in Therapeutic Nuclear Drug Business (2016-2021)
        11.7.5 Jubilant DraxImage Recent Development
    11.8 Lantheus
        11.8.1 Lantheus Company Details
        11.8.2 Lantheus Business Overview
        11.8.3 Lantheus Therapeutic Nuclear Drug Introduction
        11.8.4 Lantheus Revenue in Therapeutic Nuclear Drug Business (2016-2021)
        11.8.5 Lantheus Recent Development
    11.9 Spectrum Pharmaceuticals
        11.9.1 Spectrum Pharmaceuticals Company Details
        11.9.2 Spectrum Pharmaceuticals Business Overview
        11.9.3 Spectrum Pharmaceuticals Therapeutic Nuclear Drug Introduction
        11.9.4 Spectrum Pharmaceuticals Revenue in Therapeutic Nuclear Drug Business (2016-2021)
        11.9.5 Spectrum Pharmaceuticals Recent Development
    11.10 Progenics Pharmaceuticals
        11.10.1 Progenics Pharmaceuticals Company Details
        11.10.2 Progenics Pharmaceuticals Business Overview
        11.10.3 Progenics Pharmaceuticals Therapeutic Nuclear Drug Introduction
        11.10.4 Progenics Pharmaceuticals Revenue in Therapeutic Nuclear Drug Business (2016-2021)
        11.10.5 Progenics Pharmaceuticals Recent Development
    11.11 International Isotopes
        11.11.1 International Isotopes Company Details
        11.11.2 International Isotopes Business Overview
        11.11.3 International Isotopes Therapeutic Nuclear Drug Introduction
        11.11.4 International Isotopes Revenue in Therapeutic Nuclear Drug Business (2016-2021)
        11.11.5 International Isotopes Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Therapeutic Nuclear Drug Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Radium-223
    Table 3. Key Players of Lutetium-177
    Table 4. Key Players of Iodine-131
    Table 5. Key Players of Other
    Table 6. Global Therapeutic Nuclear Drug Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 7. Global Therapeutic Nuclear Drug Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 8. Global Therapeutic Nuclear Drug Market Size by Regions (2016-2021) & (US$ Million)
    Table 9. Global Therapeutic Nuclear Drug Market Share by Regions (2016-2021)
    Table 10. Global Therapeutic Nuclear Drug Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 11. Global Therapeutic Nuclear Drug Market Share by Regions (2022-2027)
    Table 12. Therapeutic Nuclear Drug Market Trends
    Table 13. Therapeutic Nuclear Drug Market Drivers
    Table 14. Therapeutic Nuclear Drug Market Challenges
    Table 15. Therapeutic Nuclear Drug Market Restraints
    Table 16. Global Therapeutic Nuclear Drug Revenue by Players (2016-2021) & (US$ Million)
    Table 17. Global Therapeutic Nuclear Drug Market Share by Players (2016-2021)
    Table 18. Global Top Therapeutic Nuclear Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Therapeutic Nuclear Drug as of 2020)
    Table 19. Ranking of Global Top Therapeutic Nuclear Drug Companies by Revenue (US$ Million) in 2020
    Table 20. Global 5 Largest Players Market Share by Therapeutic Nuclear Drug Revenue (CR5 and HHI) & (2016-2021)
    Table 21. Key Players Headquarters and Area Served
    Table 22. Key Players Therapeutic Nuclear Drug Product Solution and Service
    Table 23. Date of Enter into Therapeutic Nuclear Drug Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Therapeutic Nuclear Drug Market Size by Type (2016-2021) (US$ Million)
    Table 26. Global Therapeutic Nuclear Drug Revenue Market Share by Type (2016-2021)
    Table 27. Global Therapeutic Nuclear Drug Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 28. Global Therapeutic Nuclear Drug Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 29. Global Therapeutic Nuclear Drug Market Size Share by Application (2016-2021) & (US$ Million)
    Table 30. Global Therapeutic Nuclear Drug Revenue Market Share by Application (2016-2021)
    Table 31. Global Therapeutic Nuclear Drug Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 32. Global Therapeutic Nuclear Drug Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 33. North America Therapeutic Nuclear Drug Market Size by Type (2016-2021) (US$ Million)
    Table 34. North America Therapeutic Nuclear Drug Market Size by Type (2022-2027) & (US$ Million)
    Table 35. North America Therapeutic Nuclear Drug Market Size by Application (2016-2021) (US$ Million)
    Table 36. North America Therapeutic Nuclear Drug Market Size by Application (2022-2027) & (US$ Million)
    Table 37. North America Therapeutic Nuclear Drug Market Size by Country (2016-2021) & (US$ Million) 
    Table 38. North America Therapeutic Nuclear Drug Market Size by Country (2022-2027) & (US$ Million) 
    Table 39. Europe Therapeutic Nuclear Drug Market Size by Type (2016-2021) (US$ Million)
    Table 40. Europe Therapeutic Nuclear Drug Market Size by Type (2022-2027) & (US$ Million)
    Table 41. Europe Therapeutic Nuclear Drug Market Size by Application (2016-2021) (US$ Million)
    Table 42. Europe Therapeutic Nuclear Drug Market Size by Application (2022-2027) & (US$ Million)
    Table 43. Europe Therapeutic Nuclear Drug Market Size by Country (2016-2021) & (US$ Million) 
    Table 44. Europe Therapeutic Nuclear Drug Market Size by Country (2022-2027) & (US$ Million) 
    Table 45. Asia-Pacific Therapeutic Nuclear Drug Market Size by Type (2016-2021) (US$ Million)
    Table 46. Asia-Pacific Therapeutic Nuclear Drug Market Size by Type (2022-2027) & (US$ Million)
    Table 47. Asia-Pacific Therapeutic Nuclear Drug Market Size by Application (2016-2021) (US$ Million)
    Table 48. Asia-Pacific Therapeutic Nuclear Drug Market Size by Application (2022-2027) & (US$ Million)
    Table 49. Asia-Pacific Therapeutic Nuclear Drug Market Size by Region (2016-2021) & (US$ Million) 
    Table 50. Asia-Pacific Therapeutic Nuclear Drug Market Size by Region (2022-2027) & (US$ Million) 
    Table 51. Latin America Therapeutic Nuclear Drug Market Size by Type (2016-2021) (US$ Million)
    Table 52. Latin America Therapeutic Nuclear Drug Market Size by Type (2022-2027) & (US$ Million)
    Table 53. Latin America Therapeutic Nuclear Drug Market Size by Application (2016-2021) (US$ Million)
    Table 54. Latin America Therapeutic Nuclear Drug Market Size by Application (2022-2027) & (US$ Million)
    Table 55. Latin America Therapeutic Nuclear Drug Market Size by Country (2016-2021) & (US$ Million) 
    Table 56. Latin America Therapeutic Nuclear Drug Market Size by Country (2022-2027) & (US$ Million) 
    Table 57. Middle East & Africa Therapeutic Nuclear Drug Market Size by Type (2016-2021) (US$ Million)
    Table 58. Middle East & Africa Therapeutic Nuclear Drug Market Size by Type (2022-2027) & (US$ Million)
    Table 59. Middle East & Africa Therapeutic Nuclear Drug Market Size by Application (2016-2021) (US$ Million)
    Table 60. Middle East & Africa Therapeutic Nuclear Drug Market Size by Application (2022-2027) & (US$ Million)
    Table 61. Middle East & Africa Therapeutic Nuclear Drug Market Size by Country (2016-2021) & (US$ Million) 
    Table 62. Middle East & Africa Therapeutic Nuclear Drug Market Size by Country (2022-2027) & (US$ Million) 
    Table 63. Bayer Company Details
    Table 64. Bayer Business Overview
    Table 65. Bayer Therapeutic Nuclear Drug Product
    Table 66. Bayer Revenue in Therapeutic Nuclear Drug Business (2016-2021) & (US$ Million)
    Table 67. Bayer Recent Development
    Table 68. Novartis Company Details
    Table 69. Novartis Business Overview
    Table 70. Novartis Therapeutic Nuclear Drug Product
    Table 71. Novartis Revenue in Therapeutic Nuclear Drug Business (2016-2021) & (US$ Million)
    Table 72. Novartis Recent Development
    Table 73. China Isotope & Radiation Company Details
    Table 74. China Isotope & Radiation Business Overview
    Table 75. China Isotope & Radiation Therapeutic Nuclear Drug Product
    Table 76. China Isotope & Radiation Revenue in Therapeutic Nuclear Drug Business (2016-2021) & (US$ Million)
    Table 77. China Isotope & Radiation Recent Development
    Table 78. Dongcheng Company Details
    Table 79. Dongcheng Business Overview
    Table 80. Dongcheng Therapeutic Nuclear Drug Product
    Table 81. Dongcheng Revenue in Therapeutic Nuclear Drug Business (2016-2021) & (US$ Million)
    Table 82. Dongcheng Recent Development
    Table 83. Q BioMed Company Details
    Table 84. Q BioMed Business Overview
    Table 85. Q BioMed Therapeutic Nuclear Drug Product
    Table 86. Q BioMed Revenue in Therapeutic Nuclear Drug Business (2016-2021) & (US$ Million)
    Table 87. Q BioMed Recent Development
    Table 88. Curium Pharmaceuticals Company Details
    Table 89. Curium Pharmaceuticals Business Overview
    Table 90. Curium Pharmaceuticals Therapeutic Nuclear Drug Product
    Table 91. Curium Pharmaceuticals Revenue in Therapeutic Nuclear Drug Business (2016-2021) & (US$ Million)
    Table 92. Curium Pharmaceuticals Recent Development
    Table 93. Jubilant DraxImage Company Details
    Table 94. Jubilant DraxImage Business Overview
    Table 95. Jubilant DraxImage Therapeutic Nuclear Drug Product
    Table 96. Jubilant DraxImage Revenue in Therapeutic Nuclear Drug Business (2016-2021) & (US$ Million)
    Table 97. Jubilant DraxImage Recent Development
    Table 98. Lantheus Company Details
    Table 99. Lantheus Business Overview
    Table 100. Lantheus Revenue in Therapeutic Nuclear Drug Business (2016-2021) & (US$ Million)
    Table 101. Lantheus Recent Development
    Table 102. Spectrum Pharmaceuticals Company Details
    Table 103. Spectrum Pharmaceuticals Business Overview
    Table 104. Spectrum Pharmaceuticals Therapeutic Nuclear Drug Product
    Table 105. Spectrum Pharmaceuticals Revenue in Therapeutic Nuclear Drug Business (2016-2021) & (US$ Million)
    Table 106. Spectrum Pharmaceuticals Recent Development
    Table 107. Progenics Pharmaceuticals Company Details
    Table 108. Progenics Pharmaceuticals Business Overview
    Table 109. Progenics Pharmaceuticals Therapeutic Nuclear Drug Product
    Table 110. Progenics Pharmaceuticals Revenue in Therapeutic Nuclear Drug Business (2016-2021) & (US$ Million)
    Table 111. Progenics Pharmaceuticals Recent Development
    Table 112. International Isotopes Company Details
    Table 113. International Isotopes Business Overview
    Table 114. International Isotopes Therapeutic Nuclear Drug Product
    Table 115. International Isotopes Revenue in Therapeutic Nuclear Drug Business (2016-2021) & (US$ Million)
    Table 116. International Isotopes Recent Development
    Table 117. Research Programs/Design for This Report
    Table 118. Key Data Information from Secondary Sources
    Table 119. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Therapeutic Nuclear Drug Market Share by Type: 2020 VS 2027
    Figure 2. Radium-223 Features
    Figure 3. Lutetium-177 Features
    Figure 4. Iodine-131 Features
    Figure 5. Other Features
    Figure 6. Global Therapeutic Nuclear Drug Market Share by Application: 2020 VS 2027
    Figure 7. Thyroid Case Studies
    Figure 8. Bone Metastasis Case Studies
    Figure 9. Lymphoma Case Studies
    Figure 10. Other Case Studies
    Figure 11. Therapeutic Nuclear Drug Report Years Considered
    Figure 12. Global Therapeutic Nuclear Drug Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 13. Global Therapeutic Nuclear Drug Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 14. Global Therapeutic Nuclear Drug Market Share by Regions: 2020 VS 2027
    Figure 15. Global Therapeutic Nuclear Drug Market Share by Regions (2022-2027)
    Figure 16. Global Therapeutic Nuclear Drug Market Share by Players in 2020
    Figure 17. Global Top Therapeutic Nuclear Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Therapeutic Nuclear Drug as of 2020
    Figure 18. The Top 10 and 5 Players Market Share by Therapeutic Nuclear Drug Revenue in 2020
    Figure 19. Global Therapeutic Nuclear Drug Revenue Market Share by Type (2016-2021)
    Figure 20. Global Therapeutic Nuclear Drug Revenue Market Share by Type (2022-2027)
    Figure 21. North America Therapeutic Nuclear Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 22. North America Therapeutic Nuclear Drug Market Share by Type (2016-2027)
    Figure 23. North America Therapeutic Nuclear Drug Market Share by Application (2016-2027)
    Figure 24. North America Therapeutic Nuclear Drug Market Share by Country (2016-2027)
    Figure 25. United States Therapeutic Nuclear Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 26. Canada Therapeutic Nuclear Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 27. Europe Therapeutic Nuclear Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 28. Europe Therapeutic Nuclear Drug Market Share by Type (2016-2027)
    Figure 29. Europe Therapeutic Nuclear Drug Market Share by Application (2016-2027)
    Figure 30. Europe Therapeutic Nuclear Drug Market Share by Country (2016-2027)
    Figure 31. Germany Therapeutic Nuclear Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 32. France Therapeutic Nuclear Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. U.K. Therapeutic Nuclear Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. Italy Therapeutic Nuclear Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. Russia Therapeutic Nuclear Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 36. Nordic Therapeutic Nuclear Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 37. Asia-Pacific Therapeutic Nuclear Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 38. Asia-Pacific Therapeutic Nuclear Drug Market Share by Type (2016-2027)
    Figure 39. Asia-Pacific Therapeutic Nuclear Drug Market Share by Application (2016-2027)
    Figure 40. Asia-Pacific Therapeutic Nuclear Drug Market Share by Region (2016-2027)
    Figure 41. China Therapeutic Nuclear Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 42. Japan Therapeutic Nuclear Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. South Korea Therapeutic Nuclear Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. Southeast Asia Therapeutic Nuclear Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. India Therapeutic Nuclear Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 46. Australia Therapeutic Nuclear Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 47. Latin America Therapeutic Nuclear Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 48. Latin America Therapeutic Nuclear Drug Market Share by Type (2016-2027)
    Figure 49. Latin America Therapeutic Nuclear Drug Market Share by Application (2016-2027)
    Figure 50. Latin America Therapeutic Nuclear Drug Market Share by Country (2016-2027)
    Figure 51. Mexico Therapeutic Nuclear Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 52. Brazil Therapeutic Nuclear Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 53. Middle East & Africa Therapeutic Nuclear Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 54. Middle East & Africa Therapeutic Nuclear Drug Market Share by Type (2016-2027)
    Figure 55. Middle East & Africa Therapeutic Nuclear Drug Market Share by Application (2016-2027)
    Figure 56. Middle East & Africa Therapeutic Nuclear Drug Market Share by Country (2016-2027)
    Figure 57. Turkey Therapeutic Nuclear Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 58. Saudi Arabia Therapeutic Nuclear Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 59. UAE Therapeutic Nuclear Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 60. Bayer Revenue Growth Rate in Therapeutic Nuclear Drug Business (2016-2021)
    Figure 61. Novartis Revenue Growth Rate in Therapeutic Nuclear Drug Business (2016-2021)
    Figure 62. China Isotope & Radiation Revenue Growth Rate in Therapeutic Nuclear Drug Business (2016-2021)
    Figure 63. Dongcheng Revenue Growth Rate in Therapeutic Nuclear Drug Business (2016-2021)
    Figure 64. Q BioMed Revenue Growth Rate in Therapeutic Nuclear Drug Business (2016-2021)
    Figure 65. Curium Pharmaceuticals Revenue Growth Rate in Therapeutic Nuclear Drug Business (2016-2021)
    Figure 66. Jubilant DraxImage Revenue Growth Rate in Therapeutic Nuclear Drug Business (2016-2021)
    Figure 67. Lantheus Revenue Growth Rate in Therapeutic Nuclear Drug Business (2016-2021)
    Figure 68. Spectrum Pharmaceuticals Revenue Growth Rate in Therapeutic Nuclear Drug Business (2016-2021)
    Figure 69. Progenics Pharmaceuticals Revenue Growth Rate in Therapeutic Nuclear Drug Business (2016-2021)
    Figure 70. International Isotopes Revenue Growth Rate in Therapeutic Nuclear Drug Business (2016-2021)
    Figure 71. Bottom-up and Top-down Approaches for This Report
    Figure 72. Data Triangulation
    Figure 73. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Bayer
Novartis
China Isotope & Radiation
Dongcheng
Q BioMed
Curium Pharmaceuticals
Jubilant DraxImage
Lantheus
Spectrum Pharmaceuticals
Progenics Pharmaceuticals
International Isotopes
Frequently Asked Questions
Therapeutic Nuclear Drug report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Therapeutic Nuclear Drug report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Therapeutic Nuclear Drug report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Artesunate Drugs

Artesunate (AS) is a medication used to treat malaria. The intravenous form is preferred to quini ... Read More